Показано 0 из 0
Дата |
---|
09.05.2024 |
08.05.2024 |
07.05.2024 |
06.05.2024 |
03.05.2024 |
02.05.2024 |
30.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
|
|
0.64
|
0.64
|
0.695
|
0.695
|
|
|
|
|
0.645
|
0.745
|
0.64
|
0.64
|
0.69
|
0.69
|
|
|
|
|
0.645
|
0.76
|
0.63
|
0.63
|
0.69
|
0.69
|
|
|
|
|
0.645
|
0.73
|
0.615
|
0.615
|
0.675
|
0.675
|
|
|
|
|
0.66
|
0.78
|
0.74
|
0.74
|
0.74
|
0.74
|
|
|
|
|
0.71
|
0.82
|
0.75
|
0.75
|
0.75
|
0.75
|
|
|
|
|
0.725
|
0.82
|
0.77
|
0.77
|
0.77
|
0.77
|
|
|
|
|
0.755
|
0.855
|
0.755
|
0.755
|
0.805
|
0.805
|
|
|
|
|
0.78
|
0.88
|
0.73
|
0.73
|
0.755
|
0.755
|
|
|
|
|
0.77
|
0.865
|
0.74
|
0.74
|
0.76
|
0.76
|
|
|
|
|
MIRA Pharmaceuticals Inc is a life sciences company focused on the development of MIRA1a, a synthetic THC analog. MIRA1a is being developed to treat anxiety and cognitive decline in the elderly and chronic pain without impurities or the negative side effects associated with cannabis plant extracts. MIRA1a is classified as an unscheduled drug by the U.S. Drug Enforcement Administration (DEA).